Helande Innovations

Life shouldn’t revolve around pain.

We’re developing Nervida, an implant for chronic pain designed to renew relief when pain returns.

Explore Nervida

In preclinical development. Not yet available for treatment.

Two older adults enjoying a hike together in the hills.

The disruption adds up.

When relief fades, people can face more than returning pain: another appointment, another procedure, and more disruption to everyday life.

We’re developing Nervida to change what it takes to find relief again.

Treatment, relief, and the return of pain Treatment is marked at a high pain level before pain falls. As pain returns over time, a repeat treatment is marked before the second fall. This is an illustrative pattern after existing treatment, not clinical data. Pain level Time Treatment Repeat treatment Pain returns
Illustrative response to radiofrequency ablation. Timing and response vary; not Nervida results. About RFA.

Relief shouldn’t require starting over.

Nervida is an investigational implant being developed to make renewed relief possible without another invasive procedure.

In development. Clinical safety and effectiveness have not yet been established.

A longer view of care.

People living with chronic pain need relief that fits their lives. Physicians need more options to support them over time.

Helande brings clinical insight and engineering together around that shared need, with the ambition to make pain care less disruptive and everyday life more possible.

Follow Nervida’s progress.

Stay connected with Helande as we work toward more possibilities for people living with chronic pain. Receive updates on Nervida, our research, and company news.